Aqtual, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Aqtual, Inc. - overview
Established
2018
Location
Hayward, CA, US
Primary Industry
Biotechnology
About
Based in California, US, and founded in 2018, Aqtual Inc. operates as a biotechnology research company that develops and manufactures precision medicine and equipment for the treatment and monitoring of cancers and chronic diseases. The company was founded by its CEO Diana Abdueva. In July 2025, Aqtual, Inc.
raised USD 31 million in series B funding from new investors Bold Capital and BLG Advisor, with participation from returning investors Genoa Ventures, Manta Ray Ventures, and Yu Galaxy. The firm develops and produces precision drugs and devices for the monitoring and treatment of chronic conditions and cancers. It provides research and practical healthcare solutions and provides blood tests for disease detection, and monitoring. It offers healthcare solutions for inflammatory conditions, immunology, cardiovascular diseases, metabolic diseases, neurological conditions, etc.
The company will use the July 2025 funding for further research and development.
Current Investors
Genoa Ventures, Manta Ray Ventures, Yu Galaxy
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Oncology/Cancer Treatment, Therapeutic Devices, Monitoring Equipment, Diagnostic Equipment, Pharmaceutical Research & Development
Website
www.aqtual.com
Verticals
HealthTech, Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.